Appearing as a promising development in the battle against obesity, this medication is generating considerable interest . This treatment combines the action of two known GLP-1 receptor agonists, semaglutide , plus an additional glucose-dependent peptide component. Preliminary patient data have indicated impressive body decrease in people with e… Read More